M. Raptopoulougigi et al., THE EFFECT OF LORATADINE ON ACTIVATED CELLS OF THE NASAL-MUCOSA IN PATIENTS WITH ALLERGIC RHINITIS, Journal of investigational allergology & clinical immunology, 3(4), 1993, pp. 192-197
The effect of loratadine on the numbers of activated cells - cells exp
ressing interleukin-2 receptors(IL-2R), HLA-DR antigens and proliferat
ing cell nuclear antigen (PCNA) - in the nasal mucosa was studied in 4
8 patients with allergic rhinitis. Patients were treated with either l
oratadine (10 mg) or placebo for 1 month. At the end of treatment, a s
ignificant decrease in the symptom scores was noted in both groups of
patients. However, the clinical score was significantly lower in the l
oratadine group compared to the placebo group. At the end of treatment
, the numbers of IL-2R+, HLA-DR+ and PCNA+ cells were significantly de
creased only in the group on loratadine. An almost significant correla
tion was also observed between the numbers of IL-2R+ cells and symptom
s in the loratadine group. Our results show that loratadine exerts its
beneficial effect possibly by inhibiting both the action of histamine
and immune activation.